Hongqian Guo
Wannan Medical College(CN)Nanjing University of Chinese Medicine(CN)China Pharmaceutical University(CN)Hefei University(CN)Nanjing Drum Tower Hospital(CN)Higashi Osaka City General Hospital(JP)Shenzhen Children's Hospital(CN)State Key Laboratory of Pharmaceutical BiotechnologyNanjing Medical University(CN)Nanjing University(CN)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Renal and related cancers
Most-Cited Works
- → Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN(2019)356 cited
- → Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer(2023)299 cited
- → O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia(2018)293 cited
- → TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT(2015)249 cited
- → Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation(2019)181 cited
- → KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma(2021)174 cited